{
    "eid": "2-s2.0-85058911924",
    "title": "Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor Therapies in Patients with Spondyloarthritis: Analysis from the Thai Rheumatic Disease Prior Authorization Registry",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Rheumatology",
            "@code": "2745",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anti-TNF agent",
        "AS",
        "PsA",
        "spondyloarthritis",
        "survival"
    ],
    "authors": [
        "Praveena Chiowchanwisawakit",
        "Wanruchada Katchamart",
        "Manathip Osiri",
        "Pongthorn Narongroeknawin",
        "Parawee Chevaisrakul",
        "Tasanee Kitumnuaypong",
        "Boonjing Siripaitoon",
        "Worawit Louthrenoo"
    ],
    "citedby-count": 3,
    "ref-count": 38,
    "ref-list": [
        "2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis",
        "Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis",
        "Methotrexate for ankylosing spondylitis",
        "Sulfasalazine for ankylosing spondylitis",
        "Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis",
        "Six months open label trial of leflunomide in active ankylosing spondylitis",
        "Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real-life experience",
        "The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: Results from a nationwide prospective study",
        "Infliximab in combination with methotrexate in active ankylosing spondylitis: A clinical and imaging study",
        "Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria",
        "Psoriatic arthritis",
        "The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy",
        "Criteria of the classification of spondylarthropathies [in French]",
        "Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial",
        "Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)",
        "Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial",
        "Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial",
        "Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study",
        "Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression",
        "Infliximab improves signs and symptoms of psoriatic arthritis: Results of the IMPACT 2 trial",
        "Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial",
        "Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study",
        "Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)",
        "Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years",
        "Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: Findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial",
        "Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab",
        "Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: Observational study from the British Society of Rheumatology Biologics Register",
        "Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA",
        "Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: Analysis from the MonitorNet database",
        "Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: Analysis from BIOBADABRASIL",
        "Effectiveness and drug survival of TNF inhibitors in the treatment of ankylosing spondylitis: A prospective cohort study",
        "Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients - Baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice",
        "Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: Comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status. An observational cohort study from the nationwide DANBIO registry",
        "Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER",
        "Factors associated with withdrawal of the anti-TNF biologics in the treatment of rheumatic diseases: Data from the Hong Kong Biologics Registry",
        "Pharmacological therapy of spondyloarthritis",
        "Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: A prospective longitudinal observational cohort study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "118691477",
            "affilname": "Phramongkutklao Hospital and College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118691477",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}